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Abstract
Background: The direct application of photobiomodulation therapy (PBMT) using low-level laser therapy (LLLT) and
light emitting diodes (LEDs) combined with a static magnetic field (sMF) (PBMT-sMF) to target tissues is shown to
improve muscle performance and recovery. Studies have reported possible PBMT effects when a local distant to the
target tissue is irradiated. Notably, the extent of these effects on musculoskeletal performance and the optimal site
of irradiation remain unclear, although this information is clinically important since these aspects could directly
affect the magnitude of the effect. Therefore, we investigated the effects of local and non-local PBMT-sMF
irradiations on musculoskeletal performance and post-exercise recovery before an eccentric exercise protocol.
Methods: This randomized, triple-blind (participants, therapists and assessors), placebo-controlled trial included 30
healthy male volunteers randomly assigned to the placebo, local, and non-local groups. Active or placebo PBMT-
sMF was applied to 6 sites of the quadriceps muscle of both legs. An eccentric exercise protocol was used to
induce fatigue. The primary outcome was peak torque assessed by maximal voluntary contraction (MVC). The
secondary outcomes were delayed onset muscle soreness (DOMS) measured by visual analogue scale (VAS), muscle
injury assessed by serum creatine kinase activity (CK), and blood lactate levels. Evaluations were performed before
the eccentric exercise protocol (baseline), as well as immediately after and 1, 24, 48, and 72 h upon protocol
completion.
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Results: Ten volunteers were randomized per group and analysed for all outcomes. Compared to the placebo and
non-local groups, irradiation with PBMT-SMF led to statistically significant improvement (p < 0.05) with regard to all
variables in the local group. The outcomes observed in the non-local group were similar to those in the placebo
group with regard to all variables.
The volunteers did not report any adverse effects.
Conclusion: Our results support the current evidence that local irradiation of all exercised muscles promotes
ergogenic effects. PBMT-sMF improved performance and reduced muscle fatigue only when applied locally to
muscles involved in physical activity.
Trial registration: NCT03695458. Registered October 04th 2018.
Keywords: Photobiomodulation therapy, Static magnetic field, Exercise performance, Muscle performance, Muscle
recovery, Physiotherapy, Rehabilitation
Background
Photobiomodulation therapy (PBMT) refers to the appli-
cation of electromagnetic radiation to biological tissues
using low-power lasers or light-emitting diodes [1],
which induces photochemical reactions in cells leading
to a biomodulatory therapeutic effects [2, 3], without
leading to ablative or thermal adverse reactions [4]. In
recent years, this therapy has shown positive effects in
the management of several musculoskeletal disorders
and inflammatory conditions to promote pain relief and
wound healing [5–11]. Many studies have reported that
PBMT increases muscle performance, reduces fatigue,
and improves muscle recovery in athletes, physically ac-
tive, and sedentary individuals [12–22]. The main mech-
anism of action of PBMT include the interaction of
photons with cytochrome c-oxidase, a mitochondrial
photoreceptor [2], leading to greater transfer of electrons
and consequently mitochondrial respiratory chain activa-
tion, which increases mitochondrial adenosine triphos-
phate (ATP) production [23]. Another mechanism of
action for PBMT is attributed to increased microcircula-
tion [24] and increased oxygen availability [25, 26].
Static magnetic fields (sMF) are also known to affect
biological processes in the body. The sMF acts through
the movement of electrically charged particles/electro-
magnetic waves on other body parts [27, 28]. Recent
studies reported that sMF increases ATP production
[27], and reduces oxidative stress [28]. Moreover, it was
previously demonstrated that the combination of PBMT
and sMF generates greater effects in cellular metabolism
than the use of PBMT alone, through synergistic acceler-
ation of cellular electron transfer [29].
In clinical scenario, many studies have also shown that
PBMT-sMF has positive effects on muscle performance
and post-exercise recovery in athletes and non-athletes
[30–36]. Additionally, such intervention is known to im-
prove the fatigue in the lower limbs of patients with
chronic obstructive pulmonary disease [37, 38] and
stroke [39]. Moreover, this therapy used in conjunction
with different training programs has shown improved
strength [33] and aerobic endurance [34], besides de-
creased deconditioning [40].
Although these effects have been observed following the
local application of both PBMT and PBMT-sMF directly
to the exercised muscles, it has been suggested that treat-
ments at sites distant from the target tissue may also pro-
duce positive effects. On the other hand, Batista et al. [41]
did not observe positive effects when PBMT was applied
at a site distant from the target tissue.
Therefore, there is lack of consensus regarding the
non-local effects of PBMT and PBMT-sMF. To date, we
were able to identify only one clinical study that have in-
vestigated the non-local effects of PBMT on perform-
ance and recovery [42], and to the best of our
knowledge there is none study that have investigated the
non-local effects of PBMT-sMF on musculoskeletal per-
formance and recovery, particularly with the use of bio-
chemical markers to assess exercise-induced muscle
injury. It would be important to investigate whether
these effects also occur with non-local irradiation since
it could have a direct impact on the magnitude of the ef-
fect, and as consequence, in clinical practice.
Therefore, this study has as null hypothesis that non-
local treatment using PBMT-sMF is not able to promote
between group differences in functional and biochemical
markers related to skeletal muscle performance and
post-exercise recovery, and that only local PBMT-sMF
irradiation is able to promote such differences (alterna-
tive hypothesis). Thus, our aim was to investigate the ef-
fects of local and non-local PBMT-sMF irradiations on
markers of musculoskeletal performance and post-
exercise recovery before an eccentric exercise protocol
to induce muscle fatigue.
Methods
Study design
A randomized, triple-blind (participants, therapists and
assessors), placebo-controlled clinical trial approved by
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the research ethics committee (protocol number
2100849) was carried out at the Laboratory of Photo-
therapy and Innovative Technologies in Health (LaPIT),
at Nove de Julho University (UNINOVE). It was pro-
spectively registered at clinicaltrials.gov (NCT03695458).
There were no changes to the original registration while
conducting the study. All participants signed the in-
formed consent before enrollment in the study.
Sample characterization
Thirty sedentary male participants between 18 and 35
years old were recruited. All participants who agreed to
participate in the study signed an informed consent
form. The calculation of sample size (with beta value of
20% and alpha of 5%) was based on the study of Anto-
nialli et al. [30] which used the same PBMT-sMF device
and observed increased maximal voluntary contraction
(MVC; our primary outcome) at 96 h post-exercise
(336.88 ± 27.92 Nm) compared to baseline (286.63 ±
38.86 Nm). Thus, the calculation resulted in 10 volun-
teers per group (30 volunteers in total).
Even though there were no dropouts in the study, the
intention-to-treat analysis protocol, established a priori,
was followed. The flowchart CONSORT (Consolidated
Standards of Reporting Trials) shows the procedures of
this study (Fig. 1).
Inclusion and exclusion criteria
The study included male participants, aged between 18
and 35 years, with different skin pigmentations and who
performed up to 1 exercise session weekly. With no pre-
existing musculoskeletal injuries in the hips or knees in
the 2 months prior to the study.
Individuals who did not meet the above criteria were
excluded from the study, such as those using food sup-
plements, those who had chronic joint disease in the
non-dominant lower limb, or who had musculoskeletal
injury during the study.
Experimental groups and randomization
The 30 volunteers were randomly assigned to 3 experi-
mental groups (n = 10 per group) according to the type
of therapy and limb to be irradiated as described below.
 Placebo group: irradiation with placebo PBMT-sMF,
bilaterally to the anterior thigh muscles of both
lower limbs;
 Local group: irradiation with active PBMT-sMF to
the anterior thigh muscles of the exercised lower
limb and irradiation with placebo PBMT-sMF to the
anterior thigh muscles of the non-exercised limb;
 Non-local group: irradiation with placebo PBMT-
sMF to the anterior thigh muscles of the exercised
lower limb and irradiation with active PBMT-sMF
to the anterior thigh muscles of the non-exercised
limb;
Randomization was performed 2min after baseline
evaluation by a researcher who was not involved in
treatments of assessments of participants.
Randomization labels were created through the random.
org website, and a series of sealed, opaque, and num-
bered envelopes were used to ensure confidentiality and
to determine to which experimental group each volun-
teer was to be allocated.
The PBMT-sMF device was programmed by a re-
searcher who did not participate in any of the stages of
data collection and analysis. He was instructed not to
disclose the programing until the study was completed.
The device contained distinct programs, corresponding
to active PBMT-sMF or placebo. The different programs
looked the same regarding light, sound and application
time, providing adequate researcher and volunteer blind-
ness. In addition, the volunteers wore opaque glasses
which assisted in the blinding. The professionals who
evaluated MVC, CK, VAS, lactate and the one who ap-
plied the eccentric protocol was not the same one who
performed the active and placebo PBMT-sMF treat-
ments. All these procedures were performed to ensuring
triple-blind design.
Procedures
Creatine kinase (CK) activity assessment
Blood samples were collected (5 ml by anterior cubital
vein puncture) prior to stretching and warm-up (base-
line) immediately after, 1, 24, 48 and 72 h after the ec-
centric exercise protocol. Fifteen minutes after collection
the samples were centrifuged at 3000 rpm for 20 min
and the supernatant serum was stored and kept at −
80 °C until analysis.
Creatine kinase (CK) enzymatic activity as an indirect
marker of muscle damage was analyzed by spectropho-
tometry using specific reagent kits (Labtest® - Brazil) fol-
lowing the manufacturer’s instructions with the
collected blood samples.
Blood lactate assessment
Blood samples were collected from the volunteers’ finger-
tips prior to stretching and warm-up (baseline), immedi-
ately after, and 1 h after the eccentric exercise protocol.
After asepsis a puncture was performed with a disposable
lancet, the first drop of blood was discarded to prevent
contamination, then 25 μl were collected for biochemical
analysis by the electroenzymatic method according to the
instructions of the portable lactate analyzer manufacturer
(Accutrend Lactate Plus Roche, Roche Diagnostics GmbH,
Mannheim, Germany). The analyzer has a variation coeffi-
cient between 1.8 and 3.3% (intraclass correlation [ICC]
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r = 0.999), with good reliability for intra/inter-analyzers
and between test strips [43].
Evaluation of delayed onset muscle soreness (DOMS)
DOMS of exercised lower limb was evaluated by the Vis-
ual Analogue Scale (VAS), which consists of a 100 mm
line. At the beginning of the line, number 0 corresponds
to no pain and at the end, 100 corresponds to the worst
possible pain. The volunteers were instructed to draw a
line where their pain best fit at the moment. We decided
to use this method since previous research showed high
test-retest reliability for VAS in assessment of DOMS
[44]. Assessments were performed prior to stretching
and warm- up (baseline), immediately after, 1, 24, 48
and 72 h after the eccentric exercise protocol was
performed.
Stretching and warm-up
Before starting the isokinetic protocol, the volunteers
performed 3 sets of 60 s of active stretching of the knee
Fig. 1 CONSORT flowchart
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extensors/hip flexors muscles, bilaterally. Next, they
walked for 5 min at 6 km/h on a treadmill as a general
warm-up activity.
Maximum voluntary contraction (MVC) test
The muscle strength assessment and execution of the
eccentric exercise protocol for fatigue induction was per-
formed using an isokinetic dynamometer (System 4
model, Biodex Medical Systems®, Inc., Shirley, NY,
USA). Currently considered as gold standard method for
assessing the maximum capacity for muscle strength
generation and musculoskeletal performance [45, 46].
Immediately after stretching and warm-up exercises,
the volunteers performed the maximum voluntary con-
traction test (MVC). They were positioned on the seat of
the isokinetic dynamometer with a 100° angle between
the trunk and the hip, and fixed to the dynamometer
seat by belts. The non-dominant leg was positioned at
60° of knee flexion (0° corresponding to total knee ex-
tension) with the dynamometer axis parallel to the cen-
ter of the knee joint.
The MVC test consisted of three isometric contrac-
tions of knee extensors of the non-dominant leg lasting
5 s with 30-s intervals between contractions. The highest
peak torque value obtained from the three contractions
was used for statistical analysis. The volunteers were
instructed on how to perform the exercise prior to the
beginning of the MVC protocol and during the test they
were verbally encouraged by the same researcher in all
assessments. The MVC test was performed previously
(baseline), immediately after, 1, 24, 48 and 72 h after the
eccentric exercise fatigue protocol.
Photobiomodulation therapy and static magnetic field
(PBMT-sMF)
Active PBMT-sMF or active placebo was applied bilat-
erally, 2 min after baseline assessment (pre-exercise
MVC test). The application technique used was direct
skin contact and slight pressure, in 6 sites covering the
knee extensor muscles (quadriceps): 2 lateral, 2 medial
and 2 central (Fig. 2).
PBMT and sMF were applied simultaneously since these
two modalities were part of the same therapeutic device.
For such, cluster probes containing 12 diodes and a static
magnetic field were used. The cluster probes consisted in
4 laser diodes of 905 nm (0.3125mW average power, 12.5
W peak power for each diode), 4 LEDs of 875 nm (17.5
mW average power for each diode), 4 LEDs of 640 nm
(15mW average power for each diode) and a static mag-
netic field of 35 mT (device manufactured by Multi Radi-
ance Medical®, Solon - OH, USA), the total dose was 180 J
per thigh (for the active PBMT-sMF). Given the extensive
area of irradiation employed in the present work, the use
of cluster probes was paramount to optimize the therapy
Fig. 2 Treatment sites at knee extensor muscles
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application. The choice of treatment parameters and loca-
tions for PBMT-sMF were based on previous studies
using the same equipment [30, 33]. The complete descrip-
tion of the parameters is given in the Table 1.
Eccentric exercise protocol
Three minutes after the end of active or placebo PBMT-
sMF treatment the volunteers performed the eccentric
contractions protocol to induce fatigue. It consisted of
75 eccentric isokinetic contractions of the non-dominant
lower limb knee extensor muscles (5 sets of 15 repeti-
tions with 30 s interval between each set), with a velocity
of 60° sec1 (both in the eccentric and concentric phase
of the movement) and 60° range of motion (between 30°
and 90° of knee flexion). At each contraction, the dyna-
mometer automatically positioned the knees (passively)
at 30° and then flexes it to 90°. The efficiency of this
protocol has previously been demonstrated to induce
muscle damage induced by exercise [16, 30, 32].
The volunteers were instructed to resist the knee
flexion movement imposed by the dynamometer with
maximum force and during the protocol, and they were
verbally encouraged by a single assessor blinded to pa-
tients’ allocation to the different experimental groups.
Statistical analysis
The primary outcome of this study was MVC, and the
secondary outcomes were CK activity, blood lactate, and
DOMS. The intention-to-treat analysis was followed a
priori, and all data were analysed by a blinded researcher
who was not involved in the data collection. The find-
ings were tested for normality using the Kolmogorov-
Table 1 Parameters for PBMT-sMF
Number of lasers 4 Super-pulsed (infrared)
Wavelength (nm) 905 (±1)
Frequency (Hz) 250
Peak power (W) - each 12.5
Average mean optical output (mW) - each 0.3125
Power density (mW/cm2) - each 0.71
Energy density (J/cm2) - each 0.162
Dose (J) - each 0.07125
Spot size of laser (cm2) - each 0.44
Number of red LEDs 4 Red
Wavelength of red LEDs (nm) 640 (±10)
Frequency (Hz) 2
Average optical output (mW) - each 15
Power density (mW/cm2) - each 16.66
Energy density (J/cm2) - each 3.8
Dose (J) - each 3.42
Spot size of red LED (cm2) - each 0.9
Number of infrared LEDs 4 Infrared
Wavelength of infrared LEDs (nm) 875 (±10)
Frequency (Hz) 16
Average optical output (mW) - each 17.5
Power density (mW/cm2) - each 19.44
Energy density (J/cm2) - each 4.43
Dose (J) - each 3.99
Spot Size of LED (cm2) - each 0.9
Static Magnetic Field (sMT) 35
Irradiation time per site (sec) 228
Total dose per site (J) 30
Total dose applied in muscular group (J) 180
Aperture of device (cm2) 20
Application mode Cluster probe held stationary in skin contact with a 90-degree angle and slight pressure
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Smirnov test and were determined to have a normal dis-
tribution. Data were expressed as the mean and standard
deviation, and a mixed design ANOVA (repeated design
for time, non-repeated design for group) was performed
to test between-group differences at each timepoint,
followed by the Bonferroni post hoc test. Data were ana-
lyzed in terms of the absolute values and the percentage
of change based on the values established at baseline.
The analysis of the percentage of change was performed
to both decrease the data variability, and to provide a
better representation of the magnitude of changes ob-
served from the absolute data. The significance level was
set at p < 0.05. In the graphs, data are expressed as the
mean and standard error of the mean (SEM).
Results
The recruitment of volunteers was performed between
January 2019 and May 2019. Thirty male volunteers with
mean age 26.83 years (± 6.02), height 175.67 cm (± 7.95)
and body mass 73.03 kg (± 12.59) completed all
procedures of the study, there were no dropouts. Ten
volunteers were randomized per group and analyzed for
all outcomes by original assigned groups. All patients re-
ceived treatment according to the randomized allocation.
The volunteers did not report any adverse effects. Data
were analyzed and no statistically significant differences
(p > 0.05) at baseline were observed between all experi-
mental groups according for MVC, CK, blood lactate
and DOMS variables. However, statistically significant
differences (p < 0.05) were observed after the baseline
between the placebo group and the local group for
MVC, CK activity, blood lactate and DOMS. The full de-
scription of these data in absolute values, expressed as
mean, standard deviation and confidence intervals are
shown in Table 2, as well as the differences among
groups.
Regarding the percentage of change for MVC, a statis-
tically significant improvement in the peak torque (p <
0.05) was observed immediately after the eccentric exer-
cise protocol in the local group (93.13% ± 16.44)
Table 2 Functional and biochemical markers of performance and recovery in absolute values. Values are expressed as mean,
standard deviations (± SDs) and confidence intervals
Variable Group Baseline Immediately after 1 h 24 h 48 h 72 h
MVC
(Nm)
Placebo 228.28 (± 30.27) 177.21 (± 27.33) 172.98 (± 29.38) 171.21 (± 29.40) 167.65 (± 29.80) 193.15 (± 29.95)
[209.52–247.04] [160.27–194.14] [154.77–191.19] [152.99–189.43] [149.18–186.12] [174.59–211.71]
Local 231.72 (± 34.74) 213.54 (± 32.58)b 203.03 (± 30.23)b 213,74 (± 32.48)a,b 225.30 (± 29.45)a,b 249.59 (± 37.58)a,b
[210.19–253.25] [193.35–233.73] [184.29–221.77] [193.61–233.87] [207.05–243.55] [226.30–272.88]
Non-local 213.11 (± 30.04) 171.93 (± 29.88) 155.63 (± 25.18) 164.56 (± 21.51) 181.08 (± 30.32) 178.74 (± 21.74)
[194.49–231.73] [153.41–190.45] [140.02–171.24] [151.23–177.89] [162.29–199.87] [165.27–192.21]
CK
(U.L−1)
Placebo 43.87 (± 16.28) 43.31 (± 15.16) 58.51 (± 20.73) 162.31 (± 56.01) 234.97 (± 87.49) 233.60 (± 94.19)
[33.78–53.96] [33.91–52.71] [45.66–71.36] [127.60–197.02] [180.74–289.20] [175.22–291.98]
Local 38.20 (± 11.29) 34.70 (± 12.83) 35.38 (± 15.34) 69.83 (± 30.35) a,b 74.80 (± 35.68)a,b 54.53 (± 28.85) a,b
[31.20–45.20] [26.75–42.65] [25.87–44.89] [51.02–88.64] [52.69–96.91] [36.65–72.41]
Non-local 50.49 (± 12.89) 49.74 (± 15.09) 59.62 (± 16.02) 168.98 (± 61.69) 252.83 (± 118.01) 296.81 (± 88.28)
[42.50–58.48] [40.39–59.09] [49.69–69.55] [130.74–207.22] [179.69–325.97] [242.09–351.53]
DOMS
(VAS - mm)
Placebo 0 (± 0) 13.10 (± 7.56) 37.40 (± 17.42) 49.70 (± 14.25) 52.30 (± 20.12) 50.60 (± 20.38)
[0–0] [8.40–17.80] [26.60–48.20] [40.80–58.60] [39.80–64.80] [38.00–63.20]
Local 0 (± 0) 21.40 (± 14.17) 12.30 (± 14.28) a,b 16.60 (± 15.59) a,b 23.20 (± 17.83) a,b 20.40 (± 15.49) a,b
[0–0] [12.60–30.30] [3.40–21.20] [6.90–26.30] [12.20–34.20] [10.80–30.00]
Non-local 0 (± 0) 21.70 (± 11.45) 42.40 (± 25.65) 54.50 (± 30.70) 65.90 (± 27.98) 57.20 (± 31.14)
[0–0] [14.60–28.80] [26.50–58.30] [35.50–73.50] [48.50–83.30] [37.90–76.50]
Lactate
(mmol. L− 1)
Placebo 2.45 (± 0.83) 4.73 (± 1.47) 2.30 (± 0.84)
[1.94–2.96] [3.82–5.64] [1.78–2.82] – – –
Local 2.56 (± 0.44) 3.35 (± 0.76) a,b 2.14 (± 0.33)
[2.29–2.83] [2.88–3.82] [1.94–2.34] – – –
Non-local 2.06 (± 0.52) 4.62 (± 1.67) 2.31 (± 0.60)
[1.74–2.38] [3.58–5.66] [1.94–2.68] – – –
aDifferent compared to Placebo group (p < 0.05)
bDifferent compared to Non-local group (p < 0.05)
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compared to the placebo group (77.56% ± 5.62), the sta-
tistically significant difference (p < 0.05) was also ob-
served in all timepoints. A statistically significant
difference (p < 0.05) was also observed at 1 h after the
eccentric exercise protocol between the local group
(87.87% ± 7.58) and the non-local group (73.46% ±
10.08). This difference remained at 24, 48 and 72 h after
the eccentric exercise protocol, as shown in Fig. 3.
Figure 4 shows a statistically significant lower increase
(p < 0.05) in percentage of change for CK activity at 24 h
after the eccentric exercise between the local group
(188.91% ± 69.64) compared to the placebo (378.27% ±
76.42) and non-local groups (328.90% ± 57.02). This dif-
ference was also observed 48 h and 72 h after the eccen-
tric exercise protocol.
The change in blood lactate levels showed a statisti-
cally significant difference (p < 0.05) right after the ec-
centric exercise protocol for the local group (133.85% ±
35.59) compared to the placebo (198.98% ± 36.39) and
non-local groups (222.21% ± 47.80). No statistically sig-
nificant differences were observed among the groups at
1 h after the eccentric exercise protocol (Fig. 5).
Discussion
This study showed that PBMT-sMF did not increase
performance or reduce strenuous exercise-induced fa-
tigue when applied to sites distant from the exercised
muscle. This finding supports the hypothesis that
PBMT-sMF should be applied locally to muscles that
will be exercised and concurs with the results reported
by several previous studies [30, 33–36], as well as the re-
sults of current systematic reviews and meta-analyses
discussing this subject and the recently published guide-
lines [1, 14, 15]. To summarize, the maximal voluntary
contraction (MVC) in the local group was similar to that
reported by Antonialli et al. [30] who observed that ap-
plication of local PBMT-sMF using an optimal dose
(180 J/thigh) improves muscle performance. Moreover,
we observed that compared to baseline levels, muscle
strength in the local group recovered completely within
48 h after the eccentric exercise. Muscle performance in
the local group at 72 h was higher than that recorded at
baseline evaluation, indicating better performance and
more effective muscle recovery.
The eccentric exercise protocol effectively induced
muscle fatigue, as confirmed by the fact that the placebo
group showed decreased performance (based on MVC
assessment) after exercise and increased muscle damage
and fatigue. These observations were verified by estima-
tion of blood markers (creatine kinase - CK, and lactate)
and muscle pain. The group that received local PBMT-
sMF showed lesser muscle damage and a minimal in-
crease in serum CK activity within the first 24 h after ex-
ercise. The local group also showed reduced blood
lactate levels immediately after exercise. The estimation
of blood lactate shows good clinical applicability and is
Fig. 3 Percentage of change in MVC. a indicates statistical difference (p < 0.05) compared to placebo group; b indicates statistical difference (p <
0.05) compared to of non-local group
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Fig. 4 Percentage of change in CK activity. a indicates statistical difference (p < 0.05) compared to placebo group; b indicates statistical difference
(p < 0.05) compared to of non-local group
Fig. 5 Percentage of change in blood lactate levels. a indicates statistical difference (p < 0.05) compared to placebo group; b indicates statistical
difference (p < 0.05) compared to of non-local group
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widely used for performance analysis in sport settings
and because the measurement of this biochemical
marker is easy and cost effective [47, 48].
Compared to the placebo and the non-local groups,
the local group showed a statistically significant reduc-
tion in exercise-induced pain [49, 50] at 1, 24, 48, and
72 h after completion of the eccentric exercise protocol.
These results are similar to those reported by previous
studies using PBMT-sMF [30, 32], suggesting that
PBMT-sMF could increase local microcirculation [24]
and effectively removes blood metabolites, helping to re-
duces fatigue, and accelerates muscle recovery after ex-
ercise [35]. Clinically, attenuating the fatigue perception
process is important for muscle recovery because it en-
ables individuals to rapidly return to physical activities
with lesser motor impairment [51].
Our results with regard to muscle strength and recovery
from fatigue concur with those reported by Ferreira Junior
et al. [42] using PBMT only, which observed that compared
with placebo irradiation, local PBMT irradiation to the
exercised leg led to an 11.3% improvement in functional
performance. Notably, our results showed that compared
with placebo irradiation, local PBMT-sMF irradiation of
the exercised leg led to 20.07% (immediately after eccentric
protocol) to 32.78% (48 h after eccentric protocol) improve-
ment in functional performance. In our view, the greater
improvement observed in our study compared with that re-
ported by Ferreira Junior et al. [42] could be attributed to
the combination of PBMT and sMF instead the use of
PBMT only, as previously reported [52]. Moreover, Ferreira
Junior et al. [42] did not observe positive effects of PBMT
as single therapy on blood lactate levels, which can be at-
tributable to differences between the fatigue induction pro-
tocols implemented in these studies. Furthermore, Ferreira
Junior et al. [42] do not assessed the CK activity, which is
an important biochemical marker of exercise-induced
muscle injury [53]. Therefore, to determine the magnitude
of the effects of PBMT-sMF on skeletal muscles and ensure
consistent evaluation and robust results, we assessed CK
activity, since this biochemical marker is commonly used in
clinical practice to assess muscle status [53].
Some studies have reported a possible effect of PBMT
when applied distant from the target tissue [54], suggest-
ing that this effect may optimize the length of treatment
and as consequence, obviate the need to irradiate all
muscle groups involved in the exercise for instance. This
possible effect is attributed to the direct release of nitric
oxide from hemoglobin and nitrosylated myoglobin [55]
causing vasodilatation, increased blood flow, and faster re-
covery of muscles throughout the body. On the other
hand, it is also known that PBMT causes biological
changes at the cellular level secondary to interactions be-
tween photons and cytochrome c-oxidase, a mitochon-
drial enzyme, which is a cellular organelle that is not
present in the blood. The duration of this interaction
should be adequate to last until complete application of
the ideal dose, thereby achieving the desired effect on the
target tissue [2]. It must be emphasized that PBMT or
PBMT-sMF can increase or decrease cellular activity,
based on the therapeutic window and the applied dose [2,
29]. Moreover, according to the current evidence and
guidelines at least 30 s are required to promote ergogenic
effects on muscles, and the application should be per-
formed in a stationary position [1, 15].
We observed that PBMT-sMF did not produce effects
when applied to sites distant from the target area. This is
an interesting finding that highlights an important aspect
associated with the safety of this therapy and also the pos-
sibility of adverse effects, such as the non-local effects
caused by certain drugs [56]. For example, some non-
steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-
oxygenase-2 (COX-2) activity, thereby reducing inflamma-
tion and pain [56]. However, the NSAID-induced systemic
reduction in COX-2 activity may cause serious adverse ef-
fects [56], such as changes in gastric mucosal protection
[57, 58] or a high risk of myocardial infarction [59].
The lack of effects in areas distant from the irradiated
site leads to the conclusion that the interactions between
PBMT-sMF and tissues occur only at the irradiated sites.
This observation confirms that in addition to its afore-
mentioned benefits, PBMT-sMF is a safe therapeutic al-
ternative because it avoids effects, and as consequence
adverse effects, in tissues distant from the application
site. Therefore, our results highlight the relevance of
PBMT-sMF in clinical practice and reiterate the import-
ance of establishing an optimal approach for its applica-
tion using the appropriate parameters and irradiation
technique. Moreover, our findings will guide therapists
with the correct application technique to target the mus-
cles involved in exercise activity to ensure improved per-
formance and reduced fatigue [1]. In essence, partial
irradiation or irradiation of muscles not involved in a
specific activity seems to be ineffective.
A limitation of the present study is that the possible
effects of PBMT-sMF were not evaluated in tissues other
than muscles in areas distant from the irradiated site.
Therefore, further studies are needed to determine
whether PBMT-sMF affects tissues other than muscles
at sites distant from the irradiated area.
Conclusion
Our results show that PBMT-sMF irradiation can improve
performance and reduce muscle fatigue only when applied
locally to exercised muscles. No positive effects were ob-
served when a local distant from the exercised muscles
was irradiated, indicating that muscles involved in physical
activity should undergo local irradiation to achieve ergo-
genic effects of PBMT-sMF.
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